tirzepatide weight loss clinical trial on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 Day 4: Zepbound (Tirzepatide –

Understanding your bodys reactions to medications like semaglutide is crucial

Spreading depression triggers headache by activating neuronal panx1 channels

The midwest (35.8%) and south (35.6%) had the highest prevalence of obesity, and Louisiana and West Virginia were among the three states with an obesity prevalence of 40% or greater

PlexusDx patients are encouraged to communicate with their care team about all medications

In the VENTURE-Oral trial, vomiting was reported in 26% of VK2735-treated subjects vs 10% placebo

Switching formulations Over the course of long-term treatment, you may switch between compounding pharmacies, change from compounded to brand-name (or vice versa), or adjust your vial concentration for practical reasons